CAS 1589503-30-9
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Afasevikumab
CAS :Anti-IL17A/IL17F monoclonal antibody; possible use as a treatment of inflammatory diseasesAfasevikumab
CAS :Afasevikumab (RG 7624) is a fully humanised monoclonal antibody that targets and neutralises IL-17A and IL-17F,autoimmune diseases and inflammation.Degré de pureté :95%Couleur et forme :Liquid
